Sage Therapeutics
SAGE
#6947
Rank
S$0.56 B
Marketcap
$9.23
Share price
-6.92%
Change (1 day)
-58.72%
Change (1 year)

Sage Therapeutics (SAGE) - Cash on Hand

Cash on Hand as of December 2024 : S$0.67 Billion

According to Sage Therapeutics 's latest financial reports the company has S$0.67 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Sage Therapeutics - Cash on Hand chart (from 2013 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31S$0.68 B-31.07%
2023-12-31S$0.99 B-41.69%
2022-12-31S$1.70 B-27.58%
2021-12-31S$2.35 B-15.2%
2020-12-31S$2.77 B104.31%
2019-12-31S$1.35 B7.84%
2018-12-31S$1.26 B81.66%
2017-12-31S$0.69 B20.63%
2016-12-31S$0.57 B117.77%
2015-12-31S$0.26 B56.48%
2014-12-31S$0.16 B1551.97%
2013-12-31S$10.21 M198.24%
2012-12-31S$3.42 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$0.10 B-84.98%๐Ÿ‡บ๐Ÿ‡ธ USA
S$20.65 M-96.96%๐Ÿ‡บ๐Ÿ‡ธ USA
S$3.31 B 388.61%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
S$0.43 B-36.02%๐Ÿ‡บ๐Ÿ‡ธ USA